BNTX | BioNTech SE

Today
2.07
%
$
167.00
Advanced
Growth

About BioNTech

BioNTech is a biotechnology company based in Mainz, Germany that trades on Nasdaq. BioNTech develops and manufactures modern patient-specific immunotherapies for different diseases, including the Pfizer-BioNTech Covid-19 vaccine. Learn the latest information and analysis on the company, BNTX stock price today, stock news, how much one share costs and other information to help you make investment decisions. 

Check out Gainy to see insights on stock prices and more.

Even though many think the Covid pandemic is over and many of the restrictions have been lifted in countries around the world, BioNTech and its partner Pfizer signed orders for 2.4 billion Covid vaccines for 2022. We are likely to see more orders by the end of this year.

The BioNTech stock price fell by 60% in 6 months from November, 2021, which makes the current stock price of $140 a great entry point for those who expect Covid to come back. In any case, the partnership with Pfizer will give the $33 billion company a boost whatever happens.

Check back to this page for the BNTX stock quote or download Gainy to see if BNTX fits your portfolio and investment goals, get other stock quotes and recommendations that fit your portfolio and interests.

Market Data

Market
Capitalization
$
39.71B
30 days price change
21.35
%
Revenue Growth
Quarterly, YoY
-43.10
%
Volume, Today
773.69K
EV/S
1.38
%
Net Profit Margin
TTM, ANNUAL
55.60%

Ratings

null
bullish
Very bullish
Neutral
Bearish
Very Bearish
Very bullish
null
Bullish
null
Neutral
null
Bearish
null
Very Bearish
null
Price Target
$
null
Does it work for you
More information in Gainy App
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Download on the App Store
Try thematic trading fractional collections! They’re thematic, diversified, built for long-term returns, and they’re right here in our brand new web platform.
Try it now